EU Governments Are Bracing for More Covid Vaccine Delays
- AstraZeneca remains a problem, according to a diplomatic note
- Johnson & Johnson has yet to provide a delivery schedule
Photographer: Remko De Waal/AFP/Getty Images
This article is for subscribers only.
European Union governments are bracing for further possible delays in the distribution of AstraZeneca Plc’s Covid vaccine after a warning from the European Commission that the manufacturer remains a problem, according to a diplomatic note seen by Bloomberg.
Astra Chief Executive Pascal Soriot said last month the company would look at tapping international supply chains to make up for some of the shortfall, including production in the U.S. It’s revised its delivery schedule multiple times, most recently committing to 40 million doses this quarter and 180 million in the second from an earlier goal of about 280 million across both periods.